venBio Global Strategic Fund II L.P.

10% owner at Apellis Pharmaceuticals, Inc. · on record since Nov 13, 2017
10% owner at Yarrow Bioscience, Inc. · on record since Jan 29, 2018
10% owner at Akero Therapeutics, Inc. · on record since Jun 25, 2019
10% owner at Checkmate Pharmaceuticals, Inc. · on record since Aug 12, 2020
10% owner at IPI Legacy Liquidation Co · on record since Apr 29, 2021

Insider trading activity of venBio Global Strategic Fund II L.P.

Transactions on record: 31; since Nov 13, 2017

Open-market buys: 3; $13M

Open-market sells: 16; $10.5M

Companies traded: 5; last filing May 12, 2022

Figures computed from official regulatory filings — .

Companies where venBio Global Strategic Fund II L.P. has traded

Checkmate Pharmaceuticals, Inc.9 tx · $4.5M · May 12, 2022
IPI Legacy Liquidation Co8 tx · $6.8M · Apr 29, 2021
Akero Therapeutics, Inc.7 tx · $5.9M · Jul 6, 2020
Yarrow Bioscience, Inc.3 tx · $4.5M · Jan 29, 2018
Apellis Pharmaceuticals, Inc.4 tx · $1.8M · Nov 13, 2017

Track record of venBio Global Strategic Fund II L.P.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of venBio Global Strategic Fund II L.P.

Co-insiders of venBio Global Strategic Fund II L.P.

Adelman Robert JAkero Therapeutics, Inc. +1

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Checkmate Pharmaceuticals, Inc.Listing unverified	May 12, 2022	Sell	-17,700	10.38 USD	$183.7K		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	May 12, 2022	Sell	-124,525	10.39 USD	$1.3M		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	May 12, 2022	Sell	-18,676	10.38 USD	$193.9K		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	May 9, 2022	Sell	-20,743	10.37 USD	$215.1K		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	May 9, 2022	Sell	-48,334	10.37 USD	$501.2K		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	May 9, 2022	Sell	-17,600	10.37 USD	$182.5K		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	Apr 29, 2022	Sell	-73,400	10.38 USD	$761.9K		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	Apr 29, 2022	Sell	-69,230	10.38 USD	$718.6K		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	Apr 29, 2022	Sell	-47,396	10.38 USD	$492K		SEC
IPI Legacy Liquidation CoListing unverified	Apr 29, 2021	OtherD (derivative)	0	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IPI Legacy Liquidation CoListing unverified	Apr 29, 2021	OtherD (derivative)	-5,876,034	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IPI Legacy Liquidation CoListing unverified	Apr 29, 2021	OtherD (derivative)	-13,233,885	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IPI Legacy Liquidation CoListing unverified	Apr 29, 2021	Other	2,309,791	—	n/a (No price was disclosed in the filing)		SEC
IPI Legacy Liquidation CoListing unverified	Apr 29, 2021	OtherD (derivative)	-8,201,930	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IPI Legacy Liquidation CoListing unverified	Apr 29, 2021	Buy	450,000	15.00 USD	$6.8M	conv 50ClusterFirst in 12mo	SEC
IPI Legacy Liquidation CoListing unverified	Apr 29, 2021	OtherD (derivative)	-8,845,942	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IPI Legacy Liquidation CoListing unverified	Apr 26, 2021	OtherD (derivative)	0	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Akero Therapeutics, Inc.Listing unverified	Jul 6, 2020	Sell	-3,800	33.63 USD	$127.8K		SEC
Akero Therapeutics, Inc.Listing unverified	Jul 6, 2020	Sell	-4,603	33.83 USD	$155.7K		SEC
Akero Therapeutics, Inc.Listing unverified	Jul 6, 2020	Sell	-108,064	34.45 USD	$3.7M	Unusual size	SEC
Akero Therapeutics, Inc.Listing unverified	Feb 10, 2020	Sell	-6,102	27.03 USD	$164.9K		SEC
Akero Therapeutics, Inc.Listing unverified	Jan 10, 2020	Sell	-15,677	19.86 USD	$311.3K		SEC
Akero Therapeutics, Inc.Listing unverified	Jan 8, 2020	Sell	-42,221	19.64 USD	$829.2K		SEC
Akero Therapeutics, Inc.Listing unverified	Jan 8, 2020	Sell	-31,000	20.17 USD	$625.3K		SEC
Yarrow Bioscience, Inc.Security delisted	Jan 29, 2018	Other	1,196,552	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Checkmate Pharmaceuticals, Inc.Listing unverified	May 12, 2022	Sell	-17,700	10.38 USD	$183.7K		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	May 12, 2022	Sell	-124,525	10.39 USD	$1.3M		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	May 12, 2022	Sell	-18,676	10.38 USD	$193.9K		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	May 9, 2022	Sell	-20,743	10.37 USD	$215.1K		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	May 9, 2022	Sell	-48,334	10.37 USD	$501.2K		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	May 9, 2022	Sell	-17,600	10.37 USD	$182.5K		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	Apr 29, 2022	Sell	-73,400	10.38 USD	$761.9K		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	Apr 29, 2022	Sell	-69,230	10.38 USD	$718.6K		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	Apr 29, 2022	Sell	-47,396	10.38 USD	$492K		SEC
IPI Legacy Liquidation CoListing unverified	Apr 29, 2021	OtherD (derivative)	0	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IPI Legacy Liquidation CoListing unverified	Apr 29, 2021	OtherD (derivative)	-5,876,034	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IPI Legacy Liquidation CoListing unverified	Apr 29, 2021	OtherD (derivative)	-13,233,885	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IPI Legacy Liquidation CoListing unverified	Apr 29, 2021	Other	2,309,791	—	n/a (No price was disclosed in the filing)		SEC
IPI Legacy Liquidation CoListing unverified	Apr 29, 2021	OtherD (derivative)	-8,201,930	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IPI Legacy Liquidation CoListing unverified	Apr 29, 2021	Buy	450,000	15.00 USD	$6.8M	conv 50ClusterFirst in 12mo	SEC
IPI Legacy Liquidation CoListing unverified	Apr 29, 2021	OtherD (derivative)	-8,845,942	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IPI Legacy Liquidation CoListing unverified	Apr 26, 2021	OtherD (derivative)	0	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Akero Therapeutics, Inc.Listing unverified	Jul 6, 2020	Sell	-3,800	33.63 USD	$127.8K		SEC
Akero Therapeutics, Inc.Listing unverified	Jul 6, 2020	Sell	-4,603	33.83 USD	$155.7K		SEC
Akero Therapeutics, Inc.Listing unverified	Jul 6, 2020	Sell	-108,064	34.45 USD	$3.7M	Unusual size	SEC
Akero Therapeutics, Inc.Listing unverified	Feb 10, 2020	Sell	-6,102	27.03 USD	$164.9K		SEC
Akero Therapeutics, Inc.Listing unverified	Jan 10, 2020	Sell	-15,677	19.86 USD	$311.3K		SEC
Akero Therapeutics, Inc.Listing unverified	Jan 8, 2020	Sell	-42,221	19.64 USD	$829.2K		SEC
Akero Therapeutics, Inc.Listing unverified	Jan 8, 2020	Sell	-31,000	20.17 USD	$625.3K		SEC
Yarrow Bioscience, Inc.Security delisted	Jan 29, 2018	Other	1,196,552	—	n/a (No price was disclosed in the filing)		SEC